CORDARONE© | AMIODARONE 200mg

Oral Cordarone is indicated only for the treatment of severe rhythm disorders not responding to other therapies or when other treatments cannot be used: 

• Tachyarrhythmias associated with Wolff-Parkinson-White Syndrome. 
• Atrial flutter and fibrillation when other drugs cannot be used. 
• All types of tachyarrhythmias of paroxysmal nature including: supraventricular, nodal and ventricular tachycardias, ventricular fibrillation: when other drugs cannot be used.  

Pharmacotherapeutic group: antiarrhythmic class III. 

Cordarone is a product for the treatment of tachyarrhythmias and has complex pharmacological actions. Its effects are anti-adrenergic (partial alpha and beta blocker). It has haemodynamic effects (increased blood flow and systemic/coronary vasodilation). 

Please refer to the instructions on the prescription established by your medical doctor. 

Adults 

It is particularly important that the minimum effective dose be used. In all cases the patient's management must be judged on the individual response and well being. The following dosage regimen is generally effective. 

Initial Stabilisation 

Treatment should be started with 200mg, three times a day and may be continued for 1 week. The dosage should then be reduced to 200mg, twice daily for a further week. 

Maintenance 

The minimum effective dosage should be used according to individual response. It may range between 100mg daily to 400mg daily. Cordarone may be given on alternative days (200mg may be given every other day where 100mg are recommended daily); therapeutic windows have been also recommended (2 days a week): they are possible due to the prolonged therapeutic action of Cordarone.